Uterine myoma may serve as a false positive source of radioiodine uptake in whole body scintigraphy

Document Type : Case Report

Authors

Department of Nuclear Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

10.22034/irjnm.2025.129972.1673

Abstract

Understanding the occurrence of false positive results for radioactive iodine absorption in whole body scans is crucial for differentiating these cases from actual metastases. The implementation of SPECT/CT technology has significantly facilitated this process for medical professionals. This study presents a case involving a 46-year-old female patient who underwent a total thyroidectomy as a treatment for thyroid cancer (papillary thyroid carcinoma), followed by radioactive iodine therapy. The post-treatment whole body scan revealed the presence of a diffuse radioiodine-avid lesion in the pelvic region, which was later identified as multiple uterine myomas through additional investigations utilizing SPECT/low-dose CT scan and MRI findings.

Keywords

Main Subjects


  1. Choudhury PS, Gupta M. Differentiated thyroid cancer theranostics: radioiodine and beyond. Br J Radiol. 2018 Nov;91(1091):20180136.
  2. Sun YQ, Sun D, Zhang X, Zhang YQ, Lin YS. Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration. Front Endocrinol (Lausanne). 2022 Nov 30;13:994288.
  3. Giovanella L, Deandreis D, Vrachimis A, Campenni A, Petranovic Ovcaricek P. Molecular imaging and theragnostics of thyroid cancers. Cancers (Basel). 2022 Mar 1;14(5):1272.
  4. Ciarallo A, Rivera J. Radioactive iodine therapy in differentiated thyroid cancer: 2020 Update. AJR Am J Roentgenol. 2020 Aug;215(2):285-291.
  5. Abbasian H, Emami F, Banezhad F, Sadeghi R. Multiple non-malignant iodine uptake in a 131I whole body scan of a patient with papillary thyroid carcinoma: Importance of SPECT/CT. Iran J Nucl Med. 2020;28(1):39-42.
  6. Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated thyroid cancer-treatment: State of the art. Int J Mol Sci. 2017 Jun 17;18(6):1292.
  7. Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Führer D, Giovanella L, Greenspan B, Luster M, Muylle K, Smit JWA, Van Nostrand D, Verburg FA, Hegedüs L. Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: A joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019 Apr;29(4):461-470.
  8. Dohán O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 2003 Feb;24(1):48-77.
  9. Haghighatafshar M, Yazdani B. False positive radioiodine uptake in the eye, detected on SPECT/CT whole-body scan: The importance of using hybrid imaging. Iran J Nucl Med. 2024;32(2):237-240.
  10. Chambers MD, Khan MU, Chinweze M, Scott EB, Secrest SJ, Wu SY. Interesting false positive radioiodine uptake on I-131 whole body scintigraphy with different mechanisms in two patients diagnosed differentiated thyroid carcinoma: A review of literature. Clin Rev Cases. 2021;3(1):1-5.
  11. Barbaro D, Campennì A, Forleo R, Lapi P. False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer. Endocrine. 2023 Jul;81(1):30-35.
  12. Haghighatafshar M, Shekoohi-Shooli F. Adrenocortical adenoma manifesting as false-positive iodine accumulation in a patient with history of thyroid carcinoma. Radiol Case Rep. 2018 Aug 3;13(5):949-951.
  13. Farhoudi F. Delusory radioiodine uptake in endometriotic ovarian cyst. Indian J Nucl Med. 2024 May-Jun;39(3):210-212
  14. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9.
  15. Saber Tanha A, Rabani F, Raeisi N, Askari E. False-positive radioactive iodine uptake in a large uterine fibroid. Iran J Nucl Med. 2024;32(2):241-243.